天坛生物：2025年第一次临时股东会决议公告

Group 1 - The company announced the approval of two key resolutions during the 2025 first extraordinary general meeting of shareholders, including the change of the legal representative and the decision to abandon the acquisition opportunity of Palin Bio [2] - The decision to change the legal representative indicates a potential shift in management strategy or corporate governance [2] - The abandonment of the acquisition opportunity suggests a strategic refocus or reassessment of growth opportunities within the industry [2]